PTGS2 and breast neoplasm: This indicate that both COX-2 expression and enzymatic activity are important for BCSC maintenance and that the beneficial effects of COX-2 inhibitors on breast tumor recurrence and mortality are likely related to decreased BCSC self-renewal capacity.